| Followers | 85 |
| Posts | 5801 |
| Boards Moderated | 5 |
| Alias Born | 08/21/2015 |
Thursday, December 04, 2025 7:28:23 PM
Recent CMPS News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2026 09:04:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2026 09:03:11 PM
- Compass Pathways to Present at Stifel 2026 Virtual CNS Forum on March 18, 2026 • Business Wire • 03/12/2026 10:30:00 AM
- CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions • PR Newswire (US) • 03/09/2026 02:50:00 PM
- CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions • PR Newswire (Canada) • 03/09/2026 02:50:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 12:58:25 AM
- Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders • PR Newswire (US) • 02/26/2026 05:07:00 PM
- Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders • PR Newswire (Canada) • 02/26/2026 05:07:00 PM
- Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants • Business Wire • 02/26/2026 11:30:00 AM
- Compass Pathways to attend TD Cowen 46th Annual Healthcare Conference in Boston, MA from March 2-4, 2026 • Business Wire • 02/24/2026 11:39:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2026 01:50:58 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/19/2026 01:49:57 PM
- Compass Pathways Announces Pricing of $150 Million Public Offering • Business Wire • 02/19/2026 01:18:00 AM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 02/17/2026 09:46:46 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/17/2026 09:08:59 PM
- Compass Pathways Launches Proposed $150.0 Million Public Offering • Business Wire • 02/17/2026 09:06:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 11:33:23 AM
- Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression • Business Wire • 02/17/2026 11:30:00 AM
- Compass Pathways to Announce New Clinical Data from Two Ongoing Phase 3 Trials • Business Wire • 02/16/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 10:19:56 PM
- Compass Pathways gains after FDA clears IND for PTSD trial of COMP360 • IH Market News • 01/07/2026 02:59:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/07/2026 11:35:55 AM
- Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD • Business Wire • 01/07/2026 11:30:00 AM
- Compass Pathways Establishes Strategic Collaboration with Radial to Innovate Patient Experience and Inform Potential Delivery Model of COMP360 • Business Wire • 01/06/2026 11:30:00 AM
- Compass Pathways to Host Webinar on Commercial Preparations for Treatment-Resistant Depression (TRD) and Clinical Trial Plans for Post-Traumatic Stress Disorder (PTSD) on January 7, 2026, 10:00am ET • Business Wire • 12/09/2025 11:30:00 AM
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
